Market Closed -
Borsa Italiana
09:14:59 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
4.5
EUR
|
0.00%
|
|
+2.27%
|
+8.70%
|
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's profit outlook over the next few years is a strong asset.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The group usually releases upbeat results with huge surprise rates.
|
1st Jan change
|
Capi.
|
Investor Rating
|
ESG Refinitiv
|
---|
| +8.70% | 143M | |
-
| | +19.35% | 3.95B |
-
|
-
| | +1.79% | 3.04B | |
-
| | -30.07% | 1.69B |
-
|
-
| | -26.55% | 573M | |
-
| | -17.14% | 320M | |
-
| | -32.62% | 282M | |
-
| | +16.06% | 233M | |
-
| | -13.72% | 202M |
-
|
-
| | +93.92% | 132M |
-
| D+ |
4 months Revenue revision
-
Divergence of analysts' opinions
-
Divergence of Target Price
|